Volume 56, Pages S95-S98 (November 1999)

Slides:

Advertisements

Similar presentations

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Advertisements

Pathophysiology of renal fluid retention

Erythropoietin should be part of congestive heart failure management

Erythropoietin should be part of congestive heart failure management

End-stage renal disease in developing countries

Volume 56, Pages S62-S66 (November 1999)

Volume 54, Issue 1, Pages (July 1998)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Stem cells for kidney repair: useful tool for acute renal failure?

Volume 75, Issue 3, Pages (February 2009)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Zaccaria Ricci, Claudio Ronco, Sergio Picardo Kidney International

Continuous renal replacement therapy in the critically ill patient

Progression of renal failure and hypertensive nephrosclerosis

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Pathophysiology of renal fluid retention

Francesco Paolo Schena Kidney International

Volume 58, Issue 4, Pages (October 2000)

Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding Runolfur Palsson, John.

Volume 70, Pages S21-S25 (December 2006)

A new era in phosphate binder therapy: What are the options?

Volume 68, Issue 1, Pages (July 2005)

Joseph W. Eschbach, John W. Adamson Kidney International

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Prevention of renal failure: The Malaysian experience

Study of Heart and Renal Protection (SHARP)

Volume 73, Pages S5-S17 (April 2008)

Blood pressure targets in hemodialysis patients

Volume 59, Issue 4, Pages (April 2001)

Arterial function after successful renal transplantation

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Proteinuria and hypertensive nephrosclerosis in African Americans

Nephrology in Latin America, with special emphasis on Brazil

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

AGEs in foods: Do they play a role in uremia?

Volume 87, Issue 1, Pages (January 2015)

The kidney, a cardiovascular risk marker, and a new target for therapy

Counteracting progression of renal disease: A look into the future

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Circadian regulation of renal function

Biofilm in bicarbonate-based replacement fluid circuits in CVVH

Joachim Böhler, M.D., Johannes Donauer, Frieder Keller

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

The course of the remnant kidney model in mice

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Volume 56, Pages S71-S74 (November 1999)

Does equal care give equal outcomes?

Volume 55, Pages S3-S16 (June 1999)

The Danish Renal Biopsy Register

Volume 56, Pages S84-S87 (November 1999)

Volume 56, Pages S41-S45 (November 1999)

Volume 56, Pages S37-S40 (November 1999)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 68, Issue 1, Pages (July 2005)

Renal blood flow in experimental septic acute renal failure

Volume 70, Issue 10, Pages (November 2006)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Graft flow as a predictor of thrombosis in hemodialysis grafts

Morphology of the heart and arteries in renal failure

Phosphate Balance in Continuous Venovenous Hemofiltration

Presentation transcript:

Volume 56, Pages S95-S98 (November 1999) Congestive heart failure as an indication for continuous renal replacement therapy Dr Matthias Braüse, Christine E. Deppe, Markus Hollenbeck, Katrin Ivens, Frank C. Schoebel, Bernd Grabensee, Peter Heering Kidney International Volume 56, Pages S95-S98 (November 1999) DOI: 10.1046/j.1523-1755.56.s.72.4.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Time course of continuous venovenous hemofiltration (CVVH) treatment in a patient with severe congestive heart failure and massive volume overload. Symbols are: ( columns) urine output; (♦) mean arterial blood pressure; (▪) central venous pressure. Kidney International 1999 56, S95-S98DOI: (10.1046/j.1523-1755.56.s.72.4.x) Copyright © 1999 International Society of Nephrology Terms and Conditions